𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary breast cancer in patients with previous endometrial or ovarian cancer

✍ Scribed by Dr. Raymond C. Doberneck; Joseph E. Garcia


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
375 KB
Volume
37
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


The incidence of primary breast cancer is known to be increased in patients with previous endometrial or ovarian cancer, but the behavior of the breast cancer and the ultimate outlook for such patients is unknown. To provide data concerning these two questions, a group of 123 patients treated for breast cancer alone (Group I) served as a control for comparison with ten patients who had endometrial cancer (Group 11) and six patients who had ovarian cancer (Group 111) prior to diagnosis of breast cancer. The interval between the diagnosis of endometrial cancer and breast cancer averaged 4.6 yr, and between ovarian cancer and breast cancer, 5.4 yr. Age at diagnosis of breast cancer in Groups I, 11, and 111 was 56, 66 (P = 0.05) and 56 yr, respectively. The incidence of patients with stage I, 11, and 111 breast cancer was similar in Groups I, 11, and 111 as was tumor size and number of metastatic nodes in each stage in each of the three groups. Average duration of follow-up after diagnosis of breast cancer was 3, 3.1, and 2.8 yr in Groups I, 11, and 111, respectively, with 70%, 60%, and 33 % of patients living and free of either breast cancer, endometrial cancer, or ovarian cancer. Two of four deaths in Group I1 were due to endometrial cancer, and all four deaths in Group I11 were due to ovarian cancer. The remaining two deaths or recurrences in Group I1 were due to breast cancer. We conclude.that 1) the behavior of breast cancer is similar in patients with or without previous endometrial or ovarian cancer; 2) breast cancer develops at an older age in patients with previous endometrial cancer than in patients with or without previous ovarian cancer and 3) death or recurrent cancer in patients with breast cancer and previous ovarian cancer is due to ovarian cancer, whereas, death or recurrent cancer in patients with breast cancer and previous endometrial cancer is due equally to breast cancer and endometrial cancer.


πŸ“œ SIMILAR VOLUMES


Risk of endometrial and breast cancer in
✍ Elisabete Weiderpass; Gloria Gridley; Ingemar Persson; Olof NyrΓ©n; Anders Ekbom; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 39 KB πŸ‘ 2 views

Diabetes mellitus patients have metabolic and endocrine alterations that could contribute to an increased incidence of hormone-related cancers. We assessed the incidence of endometrial and breast cancer among 80,005 women and the incidence of breast cancer among 73,847 men (total of 153,852 patients

Distinguishing features of primary hyper
✍ Deborah M. Axelrod; Richard S. Bockman; George Y. Wong; Michael P. Osborne; Davi πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 496 KB πŸ‘ 2 views

Thirty-five women with breast cancer and primary hyperparathyroidism (I " H E ) were admitted to Memorial Hospital during a 25-year period. The incidence of primary hyperparathyroidism in the breast cancer patients was similar to the incidence in the total patient population at Memorial Sloan-Ketter

Outcomes in patients with primary breast
✍ Mandana Saadat; Pauline T. Truong; Hosam A. Kader; Caroline H. Speers; Eric Bert πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 150 KB

## Abstract ## BACKGROUND. The study compared tumor characteristics and survival in women with breast cancer who subsequently developed endometrial cancer with or without a history of tamoxifen use. ## METHODS. The British Columbia Cancer Agency registry identified 163 women diagnosed with breas